Delivery Order SPE2DB24D2205-SPE2DB24FDZNU

Award Date 9/6/24
Potential Completion Date 9/9/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,120.26, is for the delivery of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 6, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,800.64, is for the supply of ZORYVE 0.3% FOAM 60GM medical products. The contract is a Firm Fixed Price agreement with an ultimate completion date of November 7, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,208.58 firm fixed price delivery order is for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of June 26, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of ZORYVE 0.3% foam, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,317.12, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of November 6, 2024. The award was not designated with a set-aside requirement, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ZORYVE 0.3% FOAM 60GM, a medical product, with a ceiling value of $1,476.28 and a final completion date of February 11, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ZORYVE 0.3% cream in 60-gram units. The firm-fixed-price contract has a ceiling value of $4,823.86 and a final completion date of September 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) the DLA has with AmerisourceBergen, valued up to $999,999,999, for the provision of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,778.52 firm fixed-price delivery order contract is for the provision of ZORYVE 0.3% FOAM 60GM medical supplies. The contract has a June 3, 2024 ultimate completion date and was awarded on May 31, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
This federal contract award, with an ID of SPE2DB24D1021|SPE2DB25FERTB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,018.70, is a Firm Fixed Price Delivery Order for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award and...
This federal contract award, with an identifier of SPE2DX15D3012|SPE2DX25F8HZ7, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,609.55, is a delivery order for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, as the...
This federal contract award, valued at $6,172.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of ZORYVE 0.3% cream, a pharmaceutical product, with a period of performance through June 26, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDZNU
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product. The contract is a firm-fixed price delivery order with a ceiling value of $1,773.63 and a period of performance ending on September 9, 2024. This award is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various defense and civilian agencies to provide a wide range of medical commodities, including specialty medications, generic drugs, and medical supplies, to support government healthcare programs and military treatment facilities nationwide. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000, respectively, for the continuous supply of these essential pharmaceutical and medical products.

Generated 12/6/24, 9:29 AM